Doo-Man Kim (Doo Man Kim)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Randomized Controlled Trial

Cardiovascular Risk Factors

Top Venues

Journal of diabetes investigation

Diabetes, obesity & metabolism

Diabetes & metabolism journal

This page only lists publications with an associated author ORCID identifier.

Publications

Min Kyung Kim, Juri Park, Doo-Man Kim
Resistant starch and type 2 diabetes mellitus: Clinical perspective. Journal of diabetes investigation (2024)
Min Kyung Kim, Juri Park, Doo-Man Kim
Resistant starch and type 2 diabetes mellitus: Clinical perspective. Journal of diabetes investigation 15 (4) (2024)
Min Kyung Kim, Juri Park, Doo-Man Kim
Resistant starch and type 2 diabetes mellitus: Clinical perspective. Journal of diabetes investigation 15 (4) (2024)
Min Kyung Kim, Juri Park, Doo-Man Kim
Resistant starch and type 2 diabetes mellitus: Clinical perspective. Journal of diabetes investigation 15 (4) (2024)
Min Kyung Kim, Doo-Man Kim
Current status of diabetic kidney disease and latest trends in management. Journal of diabetes investigation 13 (12) (2022)
Eun Young Lee, Doo-Man Kim, Jae Myung Yu, Kyung Mook Choi, Sin Gon Kim, Kang Seo Park, Hyun-Shik Son, Choon Hee Chung, Kyu Jeung Ahn, Soon Hee Lee, Ki-Ho Song, Su Kyoung Kwon, Hyeong Kyu Park, Kyu Chang Won, Hak Chul Jang, null null
Anagliptin twice-daily regimen improves glycemic variability in subjects with type 2 diabetes: Double-Blind, Randomized Controlled Trial. Diabetes, obesity & metabolism (2022)
Eun Young Lee, Doo-Man Kim, Jae Myung Yu, Kyung Mook Choi, Sin Gon Kim, Kang Seo Park, Hyun-Shik Son, Choon Hee Chung, Kyu Jeung Ahn, Soon Hee Lee, Ki-Ho Song, Su Kyoung Kwon, Hyeong Kyu Park, Kyu Chang Won, Hak Chul Jang, null null
Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trial. Diabetes, obesity & metabolism (2022)
Min Kyung Kim, Doo-Man Kim
Effects of glucagon-like peptide-1 receptor agonists on kidney function and safety in type 2 diabetes patients. Journal of diabetes investigation 12 (6) (2021)
Sin Gon Kim, Kyoung Jin Kim, Kun-Ho Yoon, Sung Wan Chun, Kyong Soo Park, Kyung Mook Choi, Soo Lim, Ji-Oh Mok, Hyoung Woo Lee, Ji A Seo, Bong Soo Cha, Mi Kyung Kim, Ho Sang Shon, Dong Seop Choi, Doo-Man Kim
Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks. Diabetes, obesity & metabolism 22 (10) (2020)
Young-Joo Kim, In Kyung Jeong, Sin Gon Kim, Dong Hyeok Cho, Chong Hwa Kim, Chul Sik Kim, Won Young Lee, Kyu Chang Won, Jin Hye Cha, Juneyoung Lee, Doo-Man Kim
Changes in the Quality of Life in Patients with Type 2 Diabetes Mellitus According to Physician and Patient Behaviors. Diabetes & metabolism journal 44 (1) (2019)